Theravance Biopharma, Inc. (TBPH) › Share RepurchasesTheravance Biopharma, Inc. (TBPH): Share RepurchasesAnnual figures by period end, from SEC filings.$445.0KYear ended 2024-12-31$197.05M2022-12-31: $128.83M2023-12-31: $197.05M2024-12-31: $445.0K$445.0K2022-12-31 Share Repurchases (USD) 2024-12-31Period endedShare RepurchasesChange YoYSource filing2024-12-31$445.0K-99.8%2026-03-23, From 2024-01-012023-12-31$197.05M+53.0%2025-03-07, From 2023-01-012022-12-31$128.83Mn/a2024-03-01, From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsLong-Term DebtShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShares OutstandingWeighted Average Diluted SharesEPS (Basic)